| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for …
Over the last 12 months, insiders at Journey Medical Corporation have bought $0 and sold $0 worth of Journey Medical Corporation stock.
On average, over the past 5 years, insiders at Journey Medical Corporation have bought $379,030 and sold $279,589 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $30,400 was made by ROSENWALD LINDSAY A MD (director) on 2024‑03‑25.
| 2025-05-02 | Sale | Maraoui Claude | President & CEO | 4,834 0.0203% | $6.84 | $33,065 | +4.55% | |
| 2025-05-02 | Sale | Alloush Ramsey | COO | 2,857 0.012% | $6.84 | $19,542 | +4.55% | |
| 2025-05-02 | Sale | Benesch Joseph | CFO | 2,409 0.0101% | $6.84 | $16,478 | +4.55% | |
| 2025-03-11 | Sale | Maraoui Claude | President & CEO | 49,271 0.2294% | $5.01 | $246,848 | +43.50% | |
| 2025-03-07 | Sale | Maraoui Claude | President & CEO | 14,905 0.0691% | $5.01 | $74,674 | +43.00% | |
| 2025-03-06 | Sale | Maraoui Claude | President & CEO | 25,551 0.1233% | $5.04 | $128,777 | +45.26% | |
| 2025-03-05 | Sale | Maraoui Claude | President & CEO | 18,147 0.0847% | $5.13 | $93,094 | +40.54% | |
| 2025-03-04 | Sale | Maraoui Claude | President & CEO | 28,901 0.1365% | $5.04 | $145,661 | +44.29% | |
| 2025-03-03 | Sale | Maraoui Claude | President & CEO | 23,508 0.1159% | $5.19 | $122,007 | +45.15% | |
| 2025-02-21 | Sale | Benesch Joseph | CFO | 1,365 0.0066% | $5.19 | $7,084 | +40.66% | |
| 2024-08-01 | Sale | Benesch Joseph | CFO | 9,324 0.0422% | $5.47 | $51,002 | +1.36% | |
| 2024-07-23 | Sale | Benesch Joseph | CFO | 4,055 0.0181% | $5.40 | $21,897 | +2.59% | |
| 2024-03-25 | ROSENWALD LINDSAY A MD | director | 10,000 0.0252% | $3.04 | $30,400 | +74.32% | ||
| 2024-03-22 | Maraoui Claude | President & CEO | 10,000 0.0288% | $3.48 | $34,790 | +53.94% | ||
| 2024-03-22 | Smith Justin Adam | director | 30,000 0.0862% | $3.47 | $104,100 | +53.94% | ||
| 2024-03-22 | ROSENWALD LINDSAY A MD | director | 20,000 0.0563% | $3.40 | $68,000 | +53.94% | ||
| 2024-02-22 | Sale | Benesch Joseph | Interim CFO | 2,450 0.0076% | $3.75 | $9,188 | +31.07% | |
| 2023-11-28 | Sale | Paley Jeffrey | director | 1,745 0.0075% | $5.22 | $9,109 | -7.50% | |
| 2023-11-08 | Sale | Paley Jeffrey | director | 255 0.0008% | $3.76 | $959 | +31.78% | |
| 2023-11-07 | Sale | Paley Jeffrey | director | 2,245 0.0065% | $3.48 | $7,813 | +44.02% |
| BARRIS PETER J | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| MOTT DAVID M | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| KERINS PATRICK J | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| SANDELL SCOTT D | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| KOLLURI KRISHNA KITTU | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| DRANT RYAN D | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| Viswanathan Ravi | 10 percent owner | 3502922 12.411% | $16.25M | 1 | 0 | |
| Canaan VIII LP | 2500149 8.8581% | $11.6M | 1 | 0 | ||
| Maraoui Claude | President & CEO | 2348313 8.3202% | $10.9M | 2 | 10 | +62.13% |
| ROSENWALD LINDSAY A MD | director | 144245 0.5111% | $669,296.80 | 3 | 0 | +66.19% |
| Smith Justin Adam | director | 134717 0.4773% | $625,086.88 | 2 | 0 | +55.57% |
| Paley Jeffrey | director | 70727 0.2506% | $328,173.28 | 2 | 3 | +53.14% |
| CRAVES FRED B | 30000 0.1063% | $139,200.00 | 3 | 0 | ||
| Fust Matthew K | director | 5051 0.0179% | $23,436.64 | 1 | 4 |
$2,101,005 | 2135 | -11.51% | $64.58M | |
$131,310,609 | 62 | 26.99% | $107.44M | |
$2,767,882 | 51 | 8.70% | $24.78M | |
$30,221,759 | 51 | 0.50% | $20.6M | |
$33,884,330 | 45 | 12.56% | $223.45M |
| Increased Positions | 53 | +103.92% | 3M | +34.27% |
| Decreased Positions | 20 | -39.22% | 276,315 | -3.3% |
| New Positions | 18 | New | 2M | New |
| Sold Out Positions | 7 | Sold Out | 101,367 | Sold Out |
| Total Postitions | 84 | +64.71% | 11M | +30.98% |
| Tang Capital Management Llc | $13,817.00 | 8.83% | 1.85M | 0 | 0% | 2025-09-30 |
| Wasatch Advisors Lp | $9,732.00 | 6.22% | 1.31M | +154,213 | +13.39% | 2025-09-30 |
| Opaleye Management Inc. | $7,234.00 | 4.62% | 971,064 | +876,064 | +922.17% | 2025-09-30 |
| Blackrock, Inc. | $4,716.00 | 3.02% | 633,059 | +88,717 | +16.3% | 2025-09-30 |
| Vanguard Group Inc | $4,583.00 | 2.93% | 615,229 | +50,241 | +8.89% | 2025-09-30 |
| Summit Financial, Llc | $2,830.00 | 1.81% | 379,829 | +379,829 | New | 2025-09-30 |
| Essex Investment Management Co Llc | $2,637.00 | 1.69% | 354,021 | +125,818 | +55.13% | 2025-09-30 |
| Geode Capital Management, Llc | $2,070.00 | 1.32% | 277,846 | +15,493 | +5.91% | 2025-09-30 |
| Renaissance Technologies Llc | $1,847.00 | 1.18% | 247,900 | +4,400 | +1.81% | 2025-09-30 |
| Pale Fire Capital Se | $1,703.00 | 1.09% | 228,567 | +196,109 | +604.19% | 2025-09-30 |